DFX Intelligence

Data Factory

Private equityFirmventure with pe activity · probablelower middle market

Amoon Ventures Y.SH. Ltd.

Private Equity

Raanana

This is the graph view. The full profile, with its team, deals and sources, is on Private Equity.Open the full profile →

Search this name across graphsid dfx:pe:aae5caff-62e8-4196-b77f-c4293c1312b3

Data as of Sep 16, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 19, 2026, 7:29 PM UTC and rebuilt at most every 15 minutes.

Relationships: 112
Dated events: 24
On other graphs: 2
Observed: Sep 13, 2026 to Sep 16, 2026
26 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Venture Capitalidentity

Amoon Ventures Y.SH. Ltd.

Venture manager · shared crd

RIA / Wealth Managementidentity

AMOON VENTURES Y.SH. LTD.

Registered adviser · shared crd

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 10
PE funds: 10
Vintages: 2022 to 2022
PE GAV, 2024 filing: $939Mgross asset value on Form ADV; never dry powder
Investments: 47
Active investments: 35
Size band: LOWER MIDDLE MARKETderivedproxy: $0.94bn Private Equity Fund GAV on the Form ADV filed 2024-03-27
Latest ADV filing: Mar 27, 2024
Website: amoon.fund

Funds

Fund	Vintage	Lifecycle	ADV type	Form D sold	GAV
Amoon Growth Fund II L.P.	2022	Unknown	Private Equity Fund	n/a	$331M
Amoon Ibx Spv L.P.	2022	Early deployment	Private Equity Fund	n/a	$7.4M
Amoon Co-Investment Spv II, L.P. (satellite)	2022	Unknown	Private Equity Fund	n/a	$5.7M
Amoon Altr Spv Limited Partnership	2022	Unknown	Private Equity Fund	n/a	$6.0M
Amoon Vrct Spv Limited Partnership	2022	Unknown	Private Equity Fund	n/a	$1.3M
Amoon Mts Spv Limited Partnership	2022	Unknown	Private Equity Fund	n/a	$5.3M
Amoon Co-Investment Spv I, L.P. (seer)	2022	Unknown	Private Equity Fund	n/a	$2.8M
Amoon Scpr Spv Limited Partnership	2022	Unknown	Private Equity Fund	n/a	$8.3M
Amoon Mdcl Spv Limited Partnership	2022	Unknown	Private Equity Fund	n/a	$6.3M
Amoon 2 Fund Limited Partnership	n/a	Harvest	Private Equity Fund	n/a	$564M

Investments

Company	State	Role	Control	Invested	Exited	Status
CartiHeal	n/a	unknown	unknown	n/a	n/a	active
Theranica	n/a	unknown	unknown	n/a	n/a	active
Adicet	n/a	unknown	unknown	n/a	n/a	unknown
Akoya Biosciences	n/a	unknown	unknown	n/a	n/a	unknown
Ayala Pharmaceuticals	n/a	unknown	unknown	n/a	n/a	unknown
Biolojic Design	n/a	unknown	unknown	n/a	n/a	unknown
MetaSight	n/a	unknown	unknown	n/a	n/a	exited
Omada	n/a	unknown	unknown	n/a	n/a	unknown
Seer	n/a	unknown	unknown	n/a	n/a	unknown
Sera Prognostics	n/a	unknown	unknown	n/a	n/a	unknown
SOPHiA GENETICS	n/a	unknown	unknown	n/a	n/a	unknown
Viracta	n/a	unknown	unknown	n/a	n/a	unknown
Zebra Medical Vision	n/a	unknown	unknown	n/a	n/a	exited
Mobilion Systems	n/a	unknown	unknown	n/a	n/a	unknown
NanoGhost	n/a	unknown	unknown	n/a	n/a	active
Adcytherix	n/a	unknown	unknown	n/a	n/a	active
Mobilion Systems	n/a	unknown	unknown	n/a	n/a	active
PrognomIQ, Inc.	CA	unknown	unknown	n/a	n/a	active
Iantrek	NY	unknown	unknown	n/a	n/a	active
Rabbi Interactive	n/a	unknown	unknown	n/a	n/a	active
Positive Development	Va	unknown	unknown	n/a	n/a	active
Better Life Partners	n/a	unknown	unknown	n/a	n/a	active
Hopscotch Primary Care	n/a	unknown	unknown	n/a	n/a	active
Plexium	CA	unknown	unknown	n/a	n/a	active
Cavos	n/a	unknown	unknown	n/a	n/a	active
GraphiteRx	n/a	unknown	unknown	n/a	n/a	active
Kahr	n/a	unknown	unknown	n/a	n/a	active
Nectin Therapeutics	n/a	unknown	unknown	n/a	n/a	active
Breeoot Clinic	n/a	unknown	unknown	n/a	n/a	active
Air Doctor	n/a	unknown	unknown	n/a	n/a	active

Relationships

showing 80 of 112

Invested in (40)

→ CAVOSCompanyunknown
factDFX's own graph, The subject's own site
→ Positive DevelopmentCompanyunknown
factDFX's own graph
→ Nectin TherapeuticsCompanyunknown
factDFX's own graph, The subject's own site
→ IantrekCompanyunknown
factDFX's own graph, The subject's own site
→ Better Life PartnersCompanyunknown
factDFX's own graph, The subject's own site
→ Character BioCompanyunknown
factDFX's own graph, The subject's own site
→ Hopscotch Primary CareCompanyunknown
factDFX's own graph, The subject's own site
→ MiNA TherapeuticsCompanyunknown
factDFX's own graph, The subject's own site
→ Lin HealthCompanyunknown
factDFX's own graph, The subject's own site
→ AltruBioCompanyunknown
factDFX's own graph, The subject's own site
→ Biosplice TherapeuticsCompanyunknown
factDFX's own graph, The subject's own site
→ PlexiumCompanyunknown
factDFX's own graph, The subject's own site
→ LyfegenCompanyunknown
factDFX's own graph, The subject's own site
→ Connie HealthCompanyunknown
factDFX's own graph, The subject's own site
→ Satellite BiosciencesCompanyunknown
factDFX's own graph, The subject's own site
→ PacegenixCompanyunknown
factDFX's own graph, The subject's own site
→ Rabbi InteractiveCompanyunknown
factDFX's own graph
→ KAHRCompanyunknown
factDFX's own graph, The subject's own site
→ Scipher MedicineCompanyunknown
factDFX's own graph
→ GraphiteRxCompanyunknown
factDFX's own graph, The subject's own site
→ Biolojic DesignCompanyunknown
factDFX's own graph
→ NanoGhostCompanyunknown
factDFX's own graph, The subject's own site
→ EleosCompanyunknown
factDFX's own graph, The subject's own site
→ Ultima GenomicsCompanyunknown
factDFX's own graph
→ Mobilion SystemsCompanyunknown
factDFX's own graph
→ IBEXCompanyunknown
factDFX's own graph, The subject's own site
→ Breeoot ClinicCompanyunknown
factDFX's own graph, The subject's own site
→ CartiHealCompanyunknown
factDFX's own graph, The subject's own site
→ MDCloneCompanyunknown
factDFX's own graph, The subject's own site
→ AdcytherixCompanyunknown
factDFX's own graph, The subject's own site
and 10 more

Employs (13)

→ Yair Chaim SchindelPersonMD, MBA
factThe subject's own site
→ Tomer BerkovitzPersonManaging Partner
factThe subject's own site
→ Todd Sone, MBAPersonGeneral Partner
factThe subject's own site
→ Moshic Mor, MBAPersonGeneral Partner
factThe subject's own site
→ Sharon Feldman, PhDPersonAnalyst
factThe subject's own site
→ Yaron Daniely, PhD, MBAPersonGeneral Partner & Head of aMoon Alpha
factThe subject's own site
→ Reut Shema, PhDPersonPartner
factThe subject's own site
→ Patrick Rivers, MBAPersonPortfolio Manager
factThe subject's own site
→ Adam KotzenPersonPrincipal
factThe subject's own site
→ Hagai Marmor-Kollet, PhDPersonAssociate
factThe subject's own site
→ Rey MozerPersonMD, MBA
factThe subject's own site
→ Daniel SassPersonMD, MBA
factThe subject's own site
→ David EsraPersonMd
factThe subject's own site

Dated events

10 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Feb 23, 2026
Firm news
Yahoo! Finance Guardant buys MetaSight for $59M upfront to acquire blood test tech February 23, 2026
The subject's own siteobserved 3 days ago
Occurred
Oct 19, 2023
Firm news
GlobeNewswire Ayala Pharmaceuticals Announces Closing of Merger with Biosight October 19, 2023
The subject's own siteobserved 3 days ago
Occurred
Aug 29, 2023
Firm news
Boston Business Journal Substance-use treatment startup Better Life Partners completes $26.5M Series B fundraise August 29, 2023
The subject's own siteobserved 3 days ago
Occurred
Jul 25, 2023
Firm news
Yahoo Finance MetaSight Diagnostics Emerges from Stealth and Announces Partnership with Maccabi’s KSM Research and Innovation Center to Conduct Extensive Metabolomics Research July 25, 2023
The subject's own siteobserved 3 days ago
Occurred
Jul 17, 2023
Firm news
Yahoo Finance Scipher Medicine Signs Multi-Target Partnership with Ionis July 17, 2023
The subject's own siteobserved 3 days ago
Occurred
May 16, 2023
Firm news
Yahoo Finance MIF Invests in Nectin Therapeutics to Evaluate Nectin’s Anti-PVR Lead Drug Candidate as a Treatment for Multiple Myeloma May 16, 2023
The subject's own siteobserved 3 days ago
Occurred
Jan 1, 2023
Person joined
Osnat Tirosh joined Schedule A of Amoon Ventures Y.SH. Ltd. as Chief People Officer And Chief Of Staff
Form ADVobserved 5 days ago
Occurred
Jul 29, 2022
Person left
Michal Goren Miller (Chief Compliance Officer) no longer on Schedule A of Amoon Ventures Y.SH. Ltd.
Form ADVobserved 5 days ago
Occurred
Jul 1, 2022
Person joined
Nachum Lasson joined Schedule A of Amoon Ventures Y.SH. Ltd. as Chief Compliance Officer
Form ADVobserved 5 days ago
Occurred
Dec 1, 2021
Person joined
Irena Nmn Katsman joined Schedule A of Amoon Ventures Y.SH. Ltd. as Chief Financial Officer
Form ADVobserved 5 days ago
Occurred
Jul 1, 2021
Person joined
Noam Nmn Waldoks joined Schedule A of Amoon Ventures Y.SH. Ltd. as General Counsel
Form ADVobserved 5 days ago
Occurred
Mar 30, 2020
Person left
David Raab (Chief Operating Officer) no longer on Schedule A of Amoon Ventures Y.SH. Ltd.
Form ADVobserved 5 days ago
Occurred
Nov 1, 2019
Person joined
Bracha Nmn Sprung joined Schedule A of Amoon Ventures Y.SH. Ltd. as Chief Communications And Head Of Investor Relations And People
Form ADVobserved 5 days ago
Occurred
Mar 28, 2019
Adviser first adv filing
Amoon Ventures Y.SH. Ltd. first filed Form ADV in the extract (ERA)
Form ADVobserved 5 days ago

Show 10 bookkeeping events

Occurred
Jul 29, 2022
Amoon Vrct Spv Limited Partnership first reported on Form ADV by Amoon Ventures Y.SH. Ltd. (Private Equity Fund), GAV $7,615,830
Occurred
Jul 29, 2022
Amoon Mdcl Spv Limited Partnership first reported on Form ADV by Amoon Ventures Y.SH. Ltd. (Private Equity Fund), GAV $6,329,443
Occurred
Jul 29, 2022
Amoon Co-Investment Spv II, L.P. (satellite) first reported on Form ADV by Amoon Ventures Y.SH. Ltd. (Private Equity Fund), GAV $10,729,763
Occurred
Jul 29, 2022
Amoon Mts Spv Limited Partnership first reported on Form ADV by Amoon Ventures Y.SH. Ltd. (Private Equity Fund), GAV $5,324,771
Occurred
Jul 29, 2022
Amoon Co-Investment Spv I, L.P. (seer) first reported on Form ADV by Amoon Ventures Y.SH. Ltd. (Private Equity Fund), GAV $12,461,388
Occurred
Feb 17, 2022
Amoon Ibx Spv L.P. first reported on Form ADV by Amoon Ventures Y.SH. Ltd. (Private Equity Fund), GAV $6,303,525
Occurred
Feb 17, 2022
Amoon Growth Fund II L.P. first reported on Form ADV by Amoon Ventures Y.SH. Ltd. (Private Equity Fund), GAV $202,056,000
Occurred
Feb 17, 2022
Amoon Altr Spv Limited Partnership first reported on Form ADV by Amoon Ventures Y.SH. Ltd. (Private Equity Fund), GAV $12,403,826
Occurred
Feb 17, 2022
Amoon Scpr Spv Limited Partnership first reported on Form ADV by Amoon Ventures Y.SH. Ltd. (Private Equity Fund), GAV $5,312,290
Occurred
Mar 28, 2019
Amoon 2 Fund Limited Partnership first reported on Form ADV by Amoon Ventures Y.SH. Ltd. (Private Equity Fund), GAV $128,629,000

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 1 business phone (Form ADV), 1 office address (Form ADV), 1 website (Form ADV) · as of 2026-09-13

Yair Chaim Schindel
MD, MBA · Revealable: 1 professional profile (firm website)
Tomer Berkovitz
Managing Partner · Revealable: 1 professional profile (firm website)
Todd Sone, MBA
General Partner · Revealable: 1 professional profile (firm website)
Moshic Mor, MBA
General Partner · Revealable: 1 professional profile (firm website)
Sharon Feldman, PhD
Analyst · Revealable: 1 professional profile (firm website)
Yaron Daniely, PhD, MBA
General Partner & Head of aMoon Alpha · Revealable: 1 professional profile (firm website)
Reut Shema, PhD
Partner · Revealable: 1 professional profile (firm website)
Patrick Rivers, MBA
Portfolio Manager · Revealable: 1 professional profile (firm website)
Adam Kotzen
Principal · Revealable: 1 professional profile (firm website)
Hagai Marmor-Kollet, PhD
Associate · Revealable: 1 professional profile (firm website)
Rey Mozer
MD, MBA · Revealable: 1 professional profile (firm website)
Daniel Sass
MD, MBA · Revealable: 1 professional profile (firm website)
David Esra
MD · Revealable: 1 professional profile (firm website)

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Provenance

Graph: Private Equity
Canonical id: dfx:pe:aae5caff-62e8-4196-b77f-c4293c1312b3
First observed: Sep 13, 2026
Last observed: Sep 16, 2026 3 days ago
Source families: Federal regulator filings, Firm and issuer disclosures
3 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Amoon Ventures Y.SH. Ltd.

Private Equity

Raanana

This is the graph view. The full profile, with its team, deals and sources, is on Private Equity.Open the full profile →

Search this name across graphsid dfx:pe:aae5caff-62e8-4196-b77f-c4293c1312b3

Data as of Sep 16, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 19, 2026, 7:29 PM UTC and rebuilt at most every 15 minutes.